Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide

Nature Medicine

Volumn 10, Issue 10, 2004, Pages 1128-1132

  Kaneto, Hideaki ^a   Nakatani, Yoshihisa ^a   Miyatsuka, Takeshi ^a   Kawamori, Dan ^a   Matsuoka, Taka Aki ^a   Matsuhisa, Munehide ^a   Kajimoto, Yoshitaka ^a   Ichijo, Hidenori ^b   Yamasaki, Yoshimitsu ^a   Hori, Masatsugu ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PERMEABLE JNK INHIBITORY PEPTIDE; JNK INTERACTING PROTEIN 1; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DATA ANALYSIS; DIABETES MELLITUS; DRUG EFFICACY; GLUCOSE TOLERANCE TEST; IN VIVO STUDY; INSULIN RESISTANCE; INSULIN SYNTHESIS; MALE; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; BLOTTING, WESTERN; DIABETES MELLITUS, TYPE 2; FLUORESCEIN-5-ISOTHIOCYANATE; GENE THERAPY; IMMUNOPRECIPITATION; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, INBRED NOD; MITOGEN-ACTIVATED PROTEIN KINASE 8; MOLECULAR SEQUENCE DATA; PEPTIDES; TRANSFECTION;

ANIMALIA;

EID: 7044230885     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1111     Document Type: Article

References (25)

1. Hibi, M., Lin, A., Smeal, T., Minden, A. & Karin, M. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 7, 2135-2148 (1993).
2. Derijard, B. et al. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76, 1025-1037 (1994).
3. Davis, R. Signal transduction by the JNK group of MAP kinases. Cell 103, 239-252 (2000).
4. Chang, L. & Karin, M. Mammalian MAP kinase signalling cascades. Nature 410, 37-40 (2001).
5. Hirosumi, J, et al. A central role for JNK in obesity and insulin resistance. Nature 420, 333-336 (2002).
6. 307. J. Biol. Chem. 275, 9047-9054 (2000).
7. Manning, A.M. & Davis, R. Targeting JNK for therapeutic benefit; from junk to gold? Nature Rev. Drug Discov. 2, 554-565 (2003).
8. Kaneto, H. et al. Involvement of c-Jun N-terminal kinase in oxidative stress-mediated suppression of insulin gene expression. J. Biol. Chem. 277, 30010-30018 (2002).
9. Kawamori, D, et al. Oxidative stress induces nucleo-cytoplasmic translocation of pancreatic transcription factor PDX-1 through activation of c-Jun NH2-terminal kinase. Diabetes 52, 2896-2904 (2003).
10. Schwarze, S.R., Ho, A., Vocero-Akbani, A.M. & Dowdy, S.F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285, 1569-1572 (1999).
11. Elliott, G. & O'Hare, P. Intracellular trafficking and protein delivery by a herpesvirus structure protein. Cell 88, 223-233 (1997).
12. Frankel, A.D. & Pabo, C.O. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55, 1189-1193 (1988).
13. Kip1 induces cell migration. Nat. Med. 4, 1449-1452 (1998).
14. Rothbard, J.B. et al. Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation. Nat. Med. 6, 1253-1257 (2000).
15. Noguchi, H., Kaneto, H., Weir, G.C. & Bonner-Weir, S. PDX-1 protein containing its own Antennapedia-like protein transduction domain can transduce pancreatic duct and islet cells. Diabetes 52, 1732-1737 (2003).
16. Noguchi, H. et al. A new cell-permeable peptide allows successful allogeneic islet transplantation in mice. Nat. Med. 10, 305-309 (2004).
17. Bonny, C., Oberson, A., Negri, S., Sause, C. & Schorderet, D.F. Cell-permeable peptide inhibitors of JNK: novel blockers of β-cell death. Diabetes 50, 77-82 (2001).
18. Ichijo, H. et al. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38signaling pathways. Science 275, 90-94 (1997).
19. Tobiume, K. et al. ASK1 is required for sustained activations of JNK/p38MAP kinases and apoptosis. EMBO Rep. 2, 222-228 (2001).
20. Corbett, J.A., Wang, J.L., Sweetland, M.A., Lancaster, J.R. Jr. & McDaniel, M.L. Interleukin 1β induces the formation of nitric oxide by β-cells purified from rodent islets of Langerhans: evidence for the β-cell as a source and site of action of nitric oxide. J. Clin. Invest. 90, 2384-2391 (1992).
21. Kaneto, H. et al. Apoptotic cell death triggered by nitric oxide in pancreatic β-cells. Diabetes 44, 733-738 (1995).
22. Ammendrup, A. et al. The c-Jun amino-terminal kinase pathway is preferentially activated by interleukin-1 and controls apoptosis in differentiating pancreatic β-cells. Diabetes 49, 1468-1476 (2000).
23. Bonny, C. et al. IB1 reduces cytokine-induced apoptosis of insulin-secreting cells. J. Biol. Chem. 275, 16466-16472 (2000).
24. Mandrup-Poulsen, T. β-cell apoptosis: stimuli and signaling. Diabetes 50, S58-S63 (2001).
25. Waeber, G. et al. The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes. Nat. Genet. 24, 291-295 (2000).